Detection of V, III and i type collagens of dermal tissues in skin lesions of patients with systemic sclerosis and its implication

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 28, Issue 5, 2008, Pages 599-603

  Liu, Tong ^a   Zhang, Jian ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Immunohistochemical staining; Sclerosis, systemic; V type collagen

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 5;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHEMISTRY; DERMIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; SKIN; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; COLLAGEN TYPE I; COLLAGEN TYPE III; COLLAGEN TYPE V; DERMIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; SKIN; YOUNG ADULT;

EID: 58449132905     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-008-0525-7     Document Type: Article

References (17)

1. J. Varga D. Abraham 2007 Systemic sclerosis: a prototypic multisystem fibrotic disorder J Clin Invest 117 3 557 567
2. M. C. Ruzek S. Jha S. Ledbetter 2004 A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease Arthritis Rheum 50 4 1319 1331
3. M. Roulet F. Ruggiero G. Karsenty 2007 A comprehensive study of the spatial and temporal expression of the col5a1 gene in mouse embryos: a clue for understanding collagen V function in developing connective tissues Cell Tissue Res 327 2 323 332
4. A. P. P. Velosa W. R. Teodoro C. C. de Oliveira 2007 Collagen V nasal tolerance in experimental model of systemic sclerosis Arch Dermatol Res 299 4 177 189
5. Subcommittee for scleroderma criteria of the American Rheumatism Association DiagnosticTherapeutic Criteria Committee. 1980 Preliminary criteria for the classification of systemic sclerosis (scleroderma) Arthritis Rheum 23 5 581 590
6. M. C. Bezerra W. R. Teodoro C. C. de Oliveira 2006 Scleroderma-like remodeling induced by type V collagen Arch Dermatol Res 298 2 51 57
7. F. Verrecchia J. Laboureau O. Verola 2007 Skin involvement in scleroderma-where histological and clinical scores meet Rheumatology (Oxford) 46 5 33 841
8. S. Kahai C. P. H. Vary Y. Gao 2004 Collagen, type V, alpha1 (COL5A1) is regulated by TGF-beta in osteoblasts Matrix Biol 23 7 445 455
9. S. Yoshida A. Haque T. Mizobuchi 2006 Anti-type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well-healed lung transplants Am J Transplant 6 4 724 735
10. T. L. Sumpter D. S. Wilkes 2004 Role of autoimmunity in organ allograft rejection: a focus on immunity to type V collagen in the pathogenesis of lung transplant rejection Am J Physiol Lung Cell Mol Physiol 286 6 1129 1139
11. C. Luparello R. Sirchia 2005 Type V collagen regulates the expression of apoptotic and stress response genes by breast cancer cells J Cell Physiol 202 2 411 421
12. K. Rothblum R. C. Stahl D. J. Carey 2004 Constitutive release of alpha 4 type V collagen N-terminal domain by Schwann cells and binding to cell surface and extracellular matrix heparan sulfate proteoglycans J Biol Chem 279 49 51 282 51 288
13. H. Chanut-Delalande C. Bonod-Bidaud S. Cogne 2004 Development of a functional skin matrix requires deposition of collagen V heterotrimers Mol Cell Biol 24 13 6049 6057
14. R. J. Wenstrup J. B. Florer E. W. Brunskill 2004 Type V collagen controls the initiation of collagen fibril assembly J Biol Chem 279 51 53 331 53 337
15. R. J. Wenstrup J. B. Florer J. M. Davidson 2006 Murine model of the Ehlers-Danlos syndrome. col5α1 haploin-sufficiency disrupts collagen fibril assembly at multiple stages J Biol Chem 281 18 12 888 12 895
16. E. R. Parra W. R. Teodoro A. P. P. Velosa 2006 Interstitial and vascular type V collagen morphologic disorganization in usual interstitial pneumonia J Histochem Cytochem 54 12 1315 1325
17. P. Laplante M. A. Raymond G. Gagnon 2005 Novel fibrogenic pathways are activated in response to endothelial apoptosis: implications in the pathophysiology of systemic sclerosis J Immunol 174 9 5740 5749